CASSANDRA SEXSON: Open Payments
NPI 1932426079 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 72 payments from 10 companies in 2025. Trend: 2023 $766 · 2024 $1,404 · 2025 $926
Food & beverage: $757Education: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $239 |
| Janssen Biotech, Inc. | 9 | $138 |
| Incyte Corporation | 6 | $127 |
| Organon LLC | 15 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Amgen Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| UCB, Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
Products named: RINVOQ, TREMFYA, OPZELURA, VTAMA, DUPIXENT, OTEZLA, SKYRIZI, Sotyktu.
Industry payments across IN — which companies pay providers there.
